KM 554e-20171103112726 No_ 36 Ct-30-17-BMS.pdf · GOVERNMENT OF INDIA Directorate General of Health...
4
Transcript of KM 554e-20171103112726 No_ 36 Ct-30-17-BMS.pdf · GOVERNMENT OF INDIA Directorate General of Health...
![Page 1: KM 554e-20171103112726 No_ 36 Ct-30-17-BMS.pdf · GOVERNMENT OF INDIA Directorate General of Health Services Central Drugs Standard Control Organization (Global Clinical Trial Division)](https://reader034.fdocuments.us/reader034/viewer/2022051407/5ad21b067f8b9a05208c46dd/html5/thumbnails/1.jpg)
![Page 2: KM 554e-20171103112726 No_ 36 Ct-30-17-BMS.pdf · GOVERNMENT OF INDIA Directorate General of Health Services Central Drugs Standard Control Organization (Global Clinical Trial Division)](https://reader034.fdocuments.us/reader034/viewer/2022051407/5ad21b067f8b9a05208c46dd/html5/thumbnails/2.jpg)
![Page 3: KM 554e-20171103112726 No_ 36 Ct-30-17-BMS.pdf · GOVERNMENT OF INDIA Directorate General of Health Services Central Drugs Standard Control Organization (Global Clinical Trial Division)](https://reader034.fdocuments.us/reader034/viewer/2022051407/5ad21b067f8b9a05208c46dd/html5/thumbnails/3.jpg)
![Page 4: KM 554e-20171103112726 No_ 36 Ct-30-17-BMS.pdf · GOVERNMENT OF INDIA Directorate General of Health Services Central Drugs Standard Control Organization (Global Clinical Trial Division)](https://reader034.fdocuments.us/reader034/viewer/2022051407/5ad21b067f8b9a05208c46dd/html5/thumbnails/4.jpg)